Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Feb 5;96(2):245-57.
doi: 10.1016/j.ajhg.2014.12.013. Epub 2015 Jan 15.

CLPB mutations cause 3-methylglutaconic aciduria, progressive brain atrophy, intellectual disability, congenital neutropenia, cataracts, movement disorder

Saskia B Wortmann  1 , Szymon Ziętkiewicz  2 , Maria Kousi  3 , Radek Szklarczyk  4 , Tobias B Haack  5 , Søren W Gersting  6 , Ania C Muntau  7 , Aleksandar Rakovic  8 , G Herma Renkema  9 , Richard J Rodenburg  9 , Tim M Strom  5 , Thomas Meitinger  5 , M Estela Rubio-Gozalbo  10 , Elzbieta Chrusciel  2 , Felix Distelmaier  11 , Christelle Golzio  3 , Joop H Jansen  12 , Clara van Karnebeek  13 , Yolanda Lillquist  14 , Thomas Lücke  15 , Katrin Õunap  16 , Riina Zordania  16 , Joy Yaplito-Lee  17 , Hans van Bokhoven  18 , Johannes N Spelbrink  19 , Frédéric M Vaz  20 , Mia Pras-Raves  20 , Rafal Ploski  21 , Ewa Pronicka  22 , Christine Klein  8 , Michel A A P Willemsen  23 , Arjan P M de Brouwer  18 , Holger Prokisch  5 , Nicholas Katsanis  3 , Ron A Wevers  24
Affiliations

CLPB mutations cause 3-methylglutaconic aciduria, progressive brain atrophy, intellectual disability, congenital neutropenia, cataracts, movement disorder

Saskia B Wortmann et al. Am J Hum Genet. .

Abstract

We studied a group of individuals with elevated urinary excretion of 3-methylglutaconic acid, neutropenia that can develop into leukemia, a neurological phenotype ranging from nonprogressive intellectual disability to a prenatal encephalopathy with progressive brain atrophy, movement disorder, cataracts, and early death. Exome sequencing of two unrelated individuals and subsequent Sanger sequencing of 16 individuals with an overlapping phenotype identified a total of 14 rare, predicted deleterious alleles in CLPB in 14 individuals from 9 unrelated families. CLPB encodes caseinolytic peptidase B homolog ClpB, a member of the AAA+ protein family. To evaluate the relevance of CLPB in the pathogenesis of this syndrome, we developed a zebrafish model and an in vitro assay to measure ATPase activity. Suppression of clpb in zebrafish embryos induced a central nervous system phenotype that was consistent with cerebellar and cerebral atrophy that could be rescued by wild-type, but not mutant, human CLPB mRNA. Consistent with these data, the loss-of-function effect of one of the identified variants (c.1222A>G [p.Arg408Gly]) was supported further by in vitro evidence with the mutant peptides abolishing ATPase function. Additionally, we show that CLPB interacts biochemically with ATP2A2, known to be involved in apoptotic processes in severe congenital neutropenia (SCN) 3 (Kostmann disease [caused by HAX1 mutations]). Taken together, mutations in CLPB define a syndrome with intellectual disability, congenital neutropenia, progressive brain atrophy, movement disorder, cataracts, and 3-methylglutaconic aciduria.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Individual Photographs and MRI Findings (A) Individual #10 was born with increased muscle tone. (B and C) Study participants #11 (B) and #9 (C) with tented mouth, hypertelorism, and truncal hypotonia. (D) Individual #6 displayed no facial dysmorphisms and is able to stand freely. (E–H) Consecutive T2-weighted MR images of individual #8, axial view, at the age of 2.5 months (E), 16 months (F), 3.5 years (G), and 7 years (H), demonstrating progressive brain atrophy with both cortical and white matter volume decrease over time. Progressive, symmetrical basal ganglia atrophy was supported by abnormally increased T2 signal intensity in the caudate nucleus and putamen starting at the age of 16 months. (I) Isolated cerebellar atrophy was observed in study participant #6 as determined T1-weighted sagittal MRI.
Figure 2
Figure 2
Leucocyte Counts, Images, and Maturation Arrest (A) Leucocyte (reference range 4.5–10 g/l) and absolute neutrophil count (reference range at birth, 12–15 g/l; 2–12 months, >2 g/l; >12 months, >1.5 g/l) of individual #9 before and during successful treatment with G-CSF. (B) The total bone marrow composition at 20 months of life of the same individual: blasts 4%, promyelocytes 13%, myelocytes 1%, metamyelocytes 1%, bands and segmented cells 1%, neutrophils 2%, basophils 0%, eosinophils 8%, lymphocytes 32%, monocytes 18%, plasma-cells 0%, normoblasts 20% in comparison with a normal bone marrow. (C and D) Crista biopsy of individual #9 at 20 months of age shown in two distinct magnifications. The bone marrow contains many promyelocytes (∗), but no mature neutrophils (maturation arrest at promyelocyte stage), many macrophages, hemophagocytosis, and atypical lymphocytes.
Figure 3
Figure 3
Schematic Representation of CLBP in Human, Fungi, and Bacteria (A) The positions of all mutations identified in human. Black boxes represent the two main functional domains: the ankyrin domain (ANK) consisting of a short 34 residue repeat implicated in a wide range of protein-protein interactions and the ATPase domain (AAA+). (B) Evolutionary changes in domain composition of CLPB proteins in human, fungi (mitochondrial HSP78 and cytosolic HSP104), and bacteria. All CLPB-family homologs possess at least a single AAA+ domain and the specific CLPB-D2 domain. In contrast to human CLPB, fungi and bacteria possess an “M domain,” a ClpB N domain, and an additional AAA+ domain. Ankyrin repeats are present only in the human homolog and are probably species specific.
Figure 4
Figure 4
The CLPB Zebrafish Model In vivo complementation of four CLPB variants (p.Arg408Gly, p.Met411Ile, p.Tyr617Cys, and p.Gly646Val) identified in evaluated study participants, in zebrafish. (A–G) Dorsal view of the developing zebrafish brain stained with acetylated tubulin at 3 days postfertilization (dpf). The cerebellum (CB) is highlighted by a white dashed rectangle in (A) showing a control embryo. (A–C) Control (A), morpholino injection (B), and rescue (C) by human WT mRNA. (D–G) Illustration of the effects of the tested alleles. (H) Graphic representation of the scoring for CB defects in control and injected embryos. Coinjection of MO with WT human CLPB mRNA results is a statistically significant reduction in the number of embryos with cerebellar defects (p < 0.0001). By contrast, coinjection of MO with each of the human CLPB mRNAs carrying the four mutations tested score as pathogenic being indistinguishable from the MO-injected embryos.
Figure 5
Figure 5
Protein Interaction Network for CLPB and HAX1 A database search resulted in 17 proteins with an established physical interaction with CLPB. The live-cell screen of CLPB against a library of 100 proteins by means of bioluminescence resonance energy transfer (BRET) identified 19 additional direct interactions (Tables S4 and S5). For HAX1, a total of 38 protein interactions were listed in the BioGRID database. Within the networks of first-order protein interactions for both proteins, a link between CLPB and HAX1 is established by mutual interaction with the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SR Ca2+-ATPase 2 encoded by ATP2A2).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Acehan D., Xu Y., Stokes D.L., Schlame M. Comparison of lymphoblast mitochondria from normal subjects and patients with Barth syndrome using electron microscopic tomography. Lab. Invest. 2007;87:40–48. - PMC - PubMed
    1. Wortmann S.B., Vaz F.M., Gardeitchik T., Vissers L.E., Renkema G.H., Schuurs-Hoeijmakers J.H., Kulik W., Lammens M., Christin C., Kluijtmans L.A. Mutations in the phospholipid remodeling gene SERAC1 impair mitochondrial function and intracellular cholesterol trafficking and cause dystonia and deafness. Nat. Genet. 2012;44:797–802. - PubMed
    1. Wortmann S.B., Duran M., Anikster Y., Barth P.G., Sperl W., Zschocke J., Morava E., Wevers R.A. Inborn errors of metabolism with 3-methylglutaconic aciduria as discriminative feature: proper classification and nomenclature. J. Inherit. Metab. Dis. 2013;36:923–928. - PubMed
    1. Wortmann S.B., Espeel M., Almeida L., Reimer A., Bosboom D., Roels F., de Brouwer A.P., Wevers R.A. Inborn errors of metabolism in the biosynthesis and remodelling of phospholipids. J. Inherit. Metab. Dis. 2014 Published online September 2, 2014. - PubMed
    1. Donadieu J., Fenneteau O., Beaupain B., Mahlaoui N., Chantelot C.B. Congenital neutropenia: diagnosis, molecular bases and patient management. Orphanet J. Rare Dis. 2011;6:26. - PMC - PubMed

Publication types

MeSH terms

Substances

Supplementary concepts